Deintensified Chemoradiotherapy for Pretreatment EBV DNA–Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
J. Clin. Oncol 2022 Apr 10;40(11)1163-1173, XY Li, DH Luo, L Guo, HY Mo, R Sun, SS Guo, LT Liu, ZC Yang, JH Yang, F Qiu, XS Sun, P Wang, Q Liu, JB Li, QN Tang, C Lin, Q Yang, SL Liu, YJ Liang, GD Jia, DX Wen, CY Guo, JJ Yan, C Zhao, QY Chen, LQ Tang, HQ MaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.